Por favor, use este identificador para citar o enlazar este ítem: http://www.alice.cnptia.embrapa.br/alice/handle/doc/1166135
Registro completo de metadatos
Campo DCValorLengua/Idioma
dc.contributor.authorBARBOSA, A. de O.
dc.contributor.authorGAVA, D.
dc.contributor.authorTOCHETTO, C.
dc.contributor.authorRIBEIRO, L. C.
dc.contributor.authorBASTOS, A. P. A.
dc.contributor.authorMORES, M. A. Z.
dc.contributor.authorSCHAEFER, R.
dc.contributor.authorLIMA, M. de
dc.date.accessioned2024-07-31T19:56:59Z-
dc.date.available2024-07-31T19:56:59Z-
dc.date.created2024-07-31
dc.date.issued2024
dc.identifier.citationVaccines, v. 12, n. 845, 2024.
dc.identifier.urihttp://www.alice.cnptia.embrapa.br/alice/handle/doc/1166135-
dc.descriptionAbstract: Senecavirus A (SVA) is a picornavirus that is endemic in swine, causing a vesicular disease clinically indistinguishable from other vesicular diseases, like foot-and-mouth disease. The widespread viral circulation, constant evolution, and economic losses caused to the swine industry emphasize the need for measures to control the agent. In this study, we evaluated the immunogenicity of a whole-virus-inactivated vaccine using a representative contemporary Brazilian SVA strain in Balb/ByJ mice. The animals were vaccinated with two doses by an intramuscular route. The humoral response induced by the vaccination was evaluated by an in-house ELISA assay for IgG detection. The cellular response was assessed by flow cytometry after in vitro SVA stimulation in splenocyte cultures from vaccinated and non-vaccinated groups. Protection against SVA was assessed in the experimental groups following an oral challenge with the homologous virus. The vaccination induced high levels of IgG antibodies and the proliferation of CD45R/B220+sIgM+, CD3e+CD69+, and CD3e+CD4+CD44+CD62L− cells. These results indicate the immunogenicity and safety of the vaccine formulation in a murine model and the induction of humoral and cellular response against SVA.
dc.language.isoeng
dc.rightsopenAccess
dc.subjectRepresentative strain
dc.subjectSenecavirus A
dc.subjectCepa representativa
dc.titleImmunogenicity of an inactivated Senecavirus A vaccine with a contemporary Brazilians in mice.
dc.typeArtigo de periódico
dc.subject.thesagroVacina Inativada
dc.subject.nalthesaurusInactivated vaccines
riaa.ainfo.id1166135
riaa.ainfo.lastupdate2024-07-31
dc.identifier.doihttps://doi.org/10.3390/vaccines12080845
dc.contributor.institutionAMANDA DE OLIVEIRA BARBOSA, UNIVERSIDADE FEDERAL DE PELOTAS; DANIELLE GAVA; CAROLINE TOCHETTO; LEONARDO CLASEN RIBEIRO, UNIVERSIDADE FEDERAL DE PELOTAS; ANA PAULA ALMEIDA BASTOS, CNPSA; MARCOS ANTONIO ZANELLA MORES, CNPSA; REJANE SCHAEFER, CNPSA; MARCELO DE LIMA, UNIVERSIDADE FEDERAL DE PELOTAS.
Aparece en las colecciones:Artigo em periódico indexado (CNPSA)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
final10329-Immunogenicity-of-an-Inactivated-Senecavirus-A-Vaccine-with.pdf1.8 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem

FacebookTwitterDeliciousLinkedInGoogle BookmarksMySpace